MICHAEL WIELAND: Open Payments
NPI 1861019945 · MOLINE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 30 payments from 14 companies in 2025. Trend: 2023 $1,280 · 2024 $544 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $136 |
| Xeris Pharmaceuticals, Inc. | 4 | $68 |
| Sequel Med Tech, LLC | 2 | $47 |
| Lilly USA, LLC | 3 | $45 |
| Almatica Pharma LLC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $40 |
| Antares Pharma, Inc. | 2 | $30 |
| Averitas Pharma Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
Products named: EVENITY, TEPEZZA, GVOKE HYPOPEN, TWIIST, TERIPARATIDE, Kerendia, MOUNJARO, XYOSTED.
Industry payments across IL — which companies pay providers there.
